The Lancet Gastroenterology & Hepatology(@LancetGastroHep) 's Twitter Profileg
The Lancet Gastroenterology & Hepatology

@LancetGastroHep

The Lancet Gastroenterology & Hepatology is the world-leading #gastroenterology and #hepatology research journal. IF=35.7.

ID:701791384139866118

linkhttp://www.thelancet.com/gastrohep calendar_today22-02-2016 15:31:19

9,0K Tweets

24,0K Followers

457 Following

World Hepatitis Alliance(@Hep_Alliance) 's Twitter Profile Photo

Instead of asking questions on whether we can reach our targets by 2030, we should ask ourselves how we can reach our targets by 2030. The same goes for financing. We should focus on how we can finance viral instead of asking if we can finance it.

- Charles Gore of…

Instead of asking questions on whether we can reach our targets by 2030, we should ask ourselves how we can reach our targets by 2030. The same goes for financing. We should focus on how we can finance viral #hepatitis instead of asking if we can finance it. - @CharlieGore of…
account_circle
The Lancet Gastroenterology & Hepatology(@LancetGastroHep) 's Twitter Profile Photo

How are efforts progressing towards elimination of viral hepatitis and what needs to be done to meet 2030 targets?

Read our recent Commission update and related content ➡️ thelancet.com/commissions/vi…

How are efforts progressing towards elimination of viral hepatitis and what needs to be done to meet 2030 targets? Read our recent Commission update and related content ➡️ thelancet.com/commissions/vi… #NoHep #LiverTwitter #WorldHepatitisSummit #IntegrateAccelerateEliminate
account_circle
Philippa Matthews(@pippa_matt) 's Twitter Profile Photo

63% of new infections are in , where the lowest resources are invested in testing, treatment and research, as we have shown in our The Lancet Gastroenterology & Hepatology paper thelancet.com/journals/langa…

account_circle
World Health Organization (WHO)(@WHO) 's Twitter Profile Photo

3500 people dying globally due to hepatitis B and C infections every day: 2024 Global Hepatitis Report

is the second leading infectious cause of death globally -- with 1.3 million deaths per year

🔗 bit.ly/43Pzpeq

3500 people dying globally due to hepatitis B and C infections every day: 2024 Global Hepatitis Report #Hepatitis is the second leading infectious cause of death globally -- with 1.3 million deaths per year 🔗 bit.ly/43Pzpeq
account_circle
World Health Organization (WHO)(@WHO) 's Twitter Profile Photo

More than 6000 people are getting newly infected with viral each day.

Updated WHO estimates indicate, in 2022:
🅱️ 254 million people were living with hepatitis B
©️ 50 million with hepatitis C

🔗 bit.ly/43Pzpeq

More than 6000 people are getting newly infected with viral #hepatitis each day. Updated WHO estimates indicate, in 2022: 🅱️ 254 million people were living with hepatitis B ©️ 50 million with hepatitis C 🔗 bit.ly/43Pzpeq
account_circle
World Health Organization (WHO)(@WHO) 's Twitter Profile Photo

🅱️ B:
🧪 Only 13% of people living with chronic infection had been diagnosed
💊 Approx. 3% had received antiviral therapy at the end of 2022

©️ Hepatitis C:
🧪 Only 36% had been diagnosed
💊 20% had received curative treatment

🔗 bit.ly/43Pzpeq

🅱️ #Hepatitis B: 🧪 Only 13% of people living with chronic infection had been diagnosed 💊 Approx. 3% had received antiviral therapy at the end of 2022 ©️ Hepatitis C: 🧪 Only 36% had been diagnosed 💊 20% had received curative treatment 🔗 bit.ly/43Pzpeq
account_circle
World Hepatitis Alliance(@Hep_Alliance) 's Twitter Profile Photo

The global response is off-track towards 2030 goals to eliminate hepatitis.

Only 60% countries provide hepatitis B or C testing free of charge in the public sector fully or partially (for specific subpopulations, geographical areas, or with co-payment).

World Health Organization (WHO)

account_circle
The Lancet Gastroenterology & Hepatology(@LancetGastroHep) 's Twitter Profile Photo

🆕Our May issue is now live at thelancet.com/journals/langa…!

With RCTs in , pancreatic surgery, and pancreatic cancer, a new two-part Series on -based therapeutics, research priorities in alcohol-related liver disease, and much more!

🆕Our May issue is now live at thelancet.com/journals/langa…! With RCTs in #Crohns, pancreatic surgery, and pancreatic cancer, a new two-part Series on #microbiome-based therapeutics, research priorities in alcohol-related liver disease, and much more! #LiverTwitter #GITwitter
account_circle